GAVISCON

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: GAVISCON
Generic name: ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE
Manufacturer: Haleon US Holdings LLC
Product type: HUMAN OTC DRUG
SPL set ID: 2d74e5bc-1f10-4fb6-9258-cd906e360013
SPL ID: 4aba2043-4dde-0c18-e063-6294a90a5fcf
Version: 23
Effective date: 2026-02-13
Source export date: 2026-09-28
Source partition: 10
Source file: https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/4bbc9760f647649b787710953d978bd6419e899ba8b90f32c3d972aae43947f8/drug-label-0010-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:08:06

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 23 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M001	openfda.application_number
brand name		GAVISCON	openfda.brand_name
generic name		ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE	openfda.generic_name
manufacturer name		Haleon US Holdings LLC	openfda.manufacturer_name
ndc	package	0135-0094-41	openfda.package_ndc
ndc	package	0135-0574-01	openfda.package_ndc
ndc	package	0135-0094-42	openfda.package_ndc
ndc	package	0135-0095-41	openfda.package_ndc
ndc	product	0135-0095	openfda.product_ndc
ndc	product	0135-0574	openfda.product_ndc
ndc	product	0135-0094	openfda.product_ndc
ndc11	package	00135009442	derived:openfda.package_ndc
ndc11	package	00135009541	derived:openfda.package_ndc
ndc11	package	00135009441	derived:openfda.package_ndc
ndc11	package	00135057401	derived:openfda.package_ndc
rxcui		1251365	openfda.rxcui
rxcui		404472	openfda.rxcui
rxcui		252203	openfda.rxcui
rxcui		245001	openfda.rxcui
spl id		4aba2043-4dde-0c18-e063-6294a90a5fcf	id
spl set id		2d74e5bc-1f10-4fb6-9258-cd906e360013	set_id
unii		5QB0T2IUN0	openfda.unii
unii		0E53J927NA	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Ask a doctor or pharmacist before use if you have kidney disease are on a sodium-restricted diet or a magnesium-restricted diet are taking a prescription drug. Antacids may interact with certain prescription drugs. When using this product (Regular Strength) do not take more than 8 tablespoonfuls in 24 hours do not use the maximum dosage for more than 2 weeks except under the advice and supervision of a doctor laxative effect may occur When using this product (Extra Strength) do not take more than 16 teaspoonfuls in 24 hours do not use the maximum dosage for more than 2 weeks, except under the advice and supervision of a doctor laxative effect may occur Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.